Clinical Trials Logo

Clinical Trial Summary

The IBS registry is an observational, multi-center, real-world registry of stenting in coronary bifurcation lesions that will collect information on procedures and outcomes from various participating centers.

The aim of this registry is to investigate long-term clinical results and predictors of adverse outcomes after PCI for coronary bifurcation lesions among various participating centers.


Clinical Trial Description

Patients with coronary bifurcation lesions, if they meets all the study inclusion criteria and none of the exclusion criteria, after signing the informed consent, they will underwent PCI according to the current standard of care and will be entered in the registry. Follow-up for all subjects will continue for 5 years. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03450577
Study type Observational [Patient Registry]
Source Meshalkin Research Institute of Pathology of Circulation
Contact Dmitrii Khelimskii, MD
Phone +79137069256
Email dkhelim@mail.ru
Status Recruiting
Phase
Start date January 1, 2018
Completion date December 31, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT05731687 - Bifurcation PCI With a Hybrid Strategy With Drug Eluting Balloons Versus a Stepwise Provisional Two-stent Strategy N/A
Not yet recruiting NCT01300494 - BOVAS: Bifurcation Optimal Viewing Angle Selection Study N/A
Completed NCT01642992 - Korean Coronary Bifurcation Stenting (COBIS) Registry II N/A
Completed NCT00851526 - Coronary Bifurcation Stenting (COBIS) Registry in South Korea N/A
Completed NCT03068494 - Korean Coronary Bifurcation Stenting (COBIS) Registry III
Not yet recruiting NCT04471883 - LATAM Bif Registry